A72 Cells

A72 cells are a canine fibrosarcoma cell line derived from a spontaneously occurring tumor in a dog. These cells are used primarily in veterinary oncology research to study the biology, behavior, and treatment responses of canine fibrosarcomas. Their relevance extends to comparative oncology studies, where insights gained from canine cancers can be applied to human cancer research due to the biological similarities between certain canine and human tumors. The A72 cell line exhibits an adherent, fibroblast-like morphology and is known for its aggressive growth in vitro. It has been utilized to investigate various aspects of cancer cell biology, including proliferation, metastasis, and tumor cell interactions with the extracellular matrix. These cells are particularly valuable for assessing the efficacy of chemotherapeutic agents and exploring new therapeutic strategies, including immunotherapy and targeted therapies. A72 cells also provide a useful model for studying the molecular pathways involved in tumor growth and progression, such as signaling through the PI3K/Akt, MAPK, and other related pathways. They are instrumental in understanding the genetic and molecular underpinnings of fibrosarcoma, which can help identify potential biomarkers for diagnosis and targets for treatment in both veterinary and human oncology. Canine cell lines, Muscle, Carcinoma, Growth Conditions: Monolayer, adherent, Biosafety level: BSL 1